Biomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohort

International Journal of Cancer

Volumn 140, Issue 6, 2017, Pages 1246-1259

  Matejcic, M ^a   de Batlle, J ^a   Ricci, C ^a   Biessy, C ^a   Perrier, F ^a   Huybrechts, I ^a   Weiderpass, E ^b,c,d,f   Boutron Ruault, M C ^e,g   Cadeau, C ^e,g   His, M ^e,g   Cox, D G ^h   Boeing, H ⁱ   Fortner, R T ^j   Kaaks, R ^j   Lagiou, P ^k,l,m   Trichopoulou, A ^k,l   Benetou, V ^l   Tumino, R ⁿ   Panico, S ^o   Sieri, S ^p   Palli, D ^q   Ricceri, F ^r,s   Bueno de Mesquita, H Bas ^t,u,v   Skeie, G ^c   Amiano, P ^w,x   Sanchez M J ^w,y   Chirlaque, M D ^w,z,aa   Barricarte, A ^w,ab,ac   Quiros J R ^ad   Buckland, G ^ae   van Gils, C H ^af   Peeters, P H ^v,af   Key, T J ^ag   Riboli, E ^v   Gylling, B ^ah   Zeleniuch Jacquotte, A ^ai   Gunter, M J ^a   Romieu, I ^a   Chajes V ^a   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b FOLKHÄLSAN RESEARCH CENTER   (Finland)

^c UNIVERSITY OF TROMSØ   (Norway)

^d CANCER REGISTRY OF NORWAY   (Norway)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f KAROLINSKA INSTITUTE   (Sweden)

^g LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^h CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

ⁱ GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^j GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^k HELLENIC HEALTH FOUNDATION   (Greece)

^l UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^m HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁿ CIVILE M P AREZZO HOSPITAL   (Italy)

^o UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^p NATIONAL CANCER INSTITUTE   (Italy)

^q CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^r UNIVERSITY OF TURIN   (Italy)

^s Unit of Epidemiology   (Italy)

^t UNIVERSITY OF MALAYA   (Malaysia)

^u NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^v IMPERIAL COLLEGE LONDON   (United Kingdom)

^w CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^x BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^y UNIVERSITY OF GRANADA   (Spain)

^z DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^aa UNIVERSITY OF MURCIA   (Spain)

^ab IdiSNA Navarra Institute for Health Research   (Spain)

^ac INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^ad Public Health Dir   (Spain)

^ae CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^af UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ag UNIVERSITY OF OXFORD   (United Kingdom)

^ah UMEÅ UNIVERSITY   (Sweden)

^ai NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

alcohol; breast cancer; folate; hormone receptor status; MTHFR polymorphism; plasma biomarkers; vitamin B12

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADENINE; CYANOCOBALAMIN; CYTOSINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FOLIC ACID; PROGESTERONE RECEPTOR; THYMINE; BIOLOGICAL MARKER; ESTROGEN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN; PROGESTERONE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; CYANOCOBALAMIN BLOOD LEVEL; DNA POLYMORPHISM; FEMALE; FOLIC ACID BLOOD LEVEL; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; MTHFR GENE; POPULATION BASED CASE CONTROL STUDY; PROSPECTIVE STUDY; RISK ASSESSMENT; VITAMIN BLOOD LEVEL; ADVERSE EFFECTS; BLOOD; BREAST NEOPLASMS; CASE CONTROL STUDY; CHEMISTRY; CLINICAL TRIAL; DIET; DRINKING BEHAVIOR; EUROPE; FOLIC ACID DEFICIENCY; FOLLOW UP; GENETICS; LIFESTYLE; MIDDLE AGED; MULTICENTER STUDY; NEOPLASMS, HORMONE-DEPENDENT; PROTO ONCOGENE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN B 12 DEFICIENCY;

ADULT; AGED; ALCOHOL DRINKING; BIOMARKERS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DIET; ESTROGENS; EUROPE; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; FOLLOW-UP STUDIES; GENES, ERBB-2; HUMANS; LIFE STYLE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGESTERONE; RISK FACTORS; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 85010778037     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30536     Document Type: Article

References (58)

1. Hankinson SE, Colditz GA, Willett WC. Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res 2004;6:213–8.
2. Breast Cancer 2010 Report. Food, nutrition, physical activity, and the prevention of breast cancer. 2016.
3. Ames BN, Wakimoto P. Are vitamin and mineral deficiencies a major cancer risk?. Nat Rev Cancer 2002;2:694–704.
4. Vera-Ramirez L, Ramirez-Tortosa MC, Sanchez-Rovira P, et al. Impact of diet on breast cancer risk: a review of experimental and observational studies. Crit Rev Food Sci Nutr 2013;53:49–75.
5. Mason JB. Biomarkers of nutrient exposure and status in one-carbon (methyl) metabolism. J Nutr 2003;133(Suppl.3):941S–7S.
6. Davis CD, Uthus EO. DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med (Maywood) 2004;229:988–95.
7. Szyf M, Pakneshan P, Rabbani SA. DNA methylation and breast cancer. Biochem Pharmacol 2004;68:1187–97.
8. Rossi E, Hung J, Beilby JP, et al. Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia. Ann Epidemiol 2006;16:206–12.
9. Zhang SM, Willett WC, Selhub J, et al. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst 2003;95:373–80.
10. Wu K, Helzlsouer KJ, Comstock GW, et al. A prospective study on folate, B12, and pyridoxal 5′-phosphate (B6) and breast cancer. Cancer Epidemiol Biomarkers Prev 1999;8:209–17.
11. Lin J, Lee IM, Cook NR, et al. Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women. Am J Clin Nutr 2008;87:734–43.
12. Ericson UC, Ivarsson MI, Sonestedt E, et al. Increased breast cancer risk at high plasma folate concentrations among women with the MTHFR 677T allele. Am J Clin Nutr 2009;90:1380–9.
13. Wu W, Kang S, Zhang D. Association of vitamin B6, vitamin B12 and methionine with risk of breast cancer: a dose-response meta-analysis. Br J Cancer 2013;109:1926–44.
14. Ericson U, Sonestedt E, Gullberg B, et al. High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmo Diet and Cancer cohort. Am J Clin Nutr 2007;86:434–43.
15. Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF, et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Clin Nutr 2006;83:895–904.
16. Stevens VL, McCullough ML, Sun J, et al. Folate and other one-carbon metabolism-related nutrients and risk of postmenopausal breast cancer in the Cancer Prevention Study II Nutrition Cohort. Am J Clin Nutr 2010;91:1708–15.
17. de BJ, Ferrari P, Chajes V, et al. Dietary folate intake and breast cancer risk: European prospective investigation into cancer and nutrition. J Natl Cancer Inst 2015;107:dju367.
18. Lajous M, Romieu I, Sabia S, et al. Folate, vitamin B12 and postmenopausal breast cancer in a prospective study of French women. Cancer Causes Control 2006;17:1209–13.
19. Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr 2000;130:129–32.
20. Koushik A, Kraft P, Fuchs CS, et al. Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer. Cancer Epidemiol Biomarkers Prev 2006;15:2408–17.
21. Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol 2004;159:423–43.
22. Hazra A, Wu K, Kraft P, et al. Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses’ health study. Carcinogenesis 2007;28:1510–9.
23. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111–3.
24. van der Put NM, Gabreels F, Stevens EM, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet 1998;62:1044–51.
25. Bingham S, Riboli E. Diet and cancer – the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer 2004;4:206–15.
26. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113–24.
27. Riboli E, Kaaks R. The EPIC project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997;26(Suppl.1):S6–S14.
28. Slimani N, Deharveng G, Unwin I, et al. The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr 2007;61:1037–56.
29. Bouckaert KP, Slimani N, Nicolas G, et al. Critical evaluation of folate data in European and international databases: recommendations for standardization in international nutritional studies. Mol Nutr Food Res 2011;55:166–80.
30. Ritte R, Tikk K, Lukanova A, et al. Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study. BMC Cancer 2013;13:584.
31. Molloy AM, Scott JM. Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol 1997;281:43–53.
32. Kelleher BP, Broin SD. Microbiological assay for vitamin B12 performed in 96-well microtitre plates. J Clin Pathol 1991;44:592–5.
33. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989;8:551–61.
34. Halsted CH, Villanueva JA, Devlin AM, et al. Metabolic interactions of alcohol and folate. J Nutr 2002;132(Suppl. 8):2367S–72S.
35. Leenders M, Ros MM, Sluijs I, et al. Reliability of selected antioxidants and compounds involved in one-carbon metabolism in two Dutch cohorts. Nutr Cancer 2013;65:17–24.
36. Pfeiffer CM, Johnson CL, Jain RB, et al. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004. Am J Clin Nutr 2007;86:718–27.
37. MMWR. Trends in wheat-flour fortification with folic acid and iron–worldwide, 2004 and 2007. MMWR Morb Mortal Wkly Rep 2008;57:8–10.
38. Caudill MA. Folate bioavailability: implications for establishing dietary recommendations and optimizing status. Am J Clin Nutr 2010;91:1455S–60S.
39. Chen P, Li C, Li X, et al. Higher dietary folate intake reduces the breast cancer risk: a systematic review and meta-analysis. Br J Cancer 2014;110:2327–38.
40. Kim YI. Does a high folate intake increase the risk of breast cancer?. Nutr Rev 2006;64(10 Part 1):468–75.
41. Lalouschek W, Aull S, Serles W, et al. Genetic and nongenetic factors influencing plasma homocysteine levels in patients with ischemic cerebrovascular disease and in healthy control subjects. J Lab Clin Med 1999;133:575–82.
42. Bassett JK, Baglietto L, Hodge AM, et al. Dietary intake of B vitamins and methionine and breast cancer risk. Cancer Causes Control 2013;24:1555–63.
43. Powers HJ. Interaction among folate, riboflavin, genotype, and cancer, with reference to colorectal and cervical cancer. J Nutr 2005;135(Suppl. 12):2960S–6S.
44. Baylin SB, Herman JG, Graff JR, et al. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998;72:141–96.
45. Widschwendter M, Jones PA. DNA methylation and breast carcinogenesis. Oncogene 2002;21:5462–82.
46. Gonzalgo ML, Jones PA. Mutagenic and epigenetic effects of DNA methylation. Mutat Res 1997;386:107–18.
47. Laufer EM, Hartman TJ, Baer DJ, et al. Effects of moderate alcohol consumption on folate and vitamin B(12) status in postmenopausal women. Eur J Clin Nutr 2004;58:1518–24.
48. Cylwik B, Czygier M, Daniluk M, et al. Vitamin B12 concentration in the blood of alcoholics. Pol Merkur Lekarski 2010;28:122–5.
49. Kabat GC, Miller AB, Jain M, et al. Dietary intake of selected B vitamins in relation to risk of major cancers in women. Br J Cancer 2008;99:816–21.
50. Cho E, Holmes M, Hankinson SE, et al. Nutrients involved in one-carbon metabolism and risk of breast cancer among premenopausal women. Cancer Epidemiol Biomarkers Prev 2007;16:2787–90.
51. Fazili Z, Pfeiffer CM. Measurement of folates in serum and conventionally prepared whole blood lysates: application of an automated 96-well plate isotope-dilution tandem mass spectrometry method. Clin Chem 2004;50:2378–81.
52. Crider KS, Yang TP, Berry RJ, et al. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. Adv Nutr 2012;3:21–38.
53. Chen J, Gammon MD, Chan W, et al. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res 2005;65:1606–14.
54. Shrubsole MJ, Gao YT, Cai Q, et al. MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 2004;13:190–6.
55. Maruti SS, Ulrich CM, Jupe ER, et al. MTHFR C677T and postmenopausal breast cancer risk by intakes of one-carbon metabolism nutrients: a nested case-control study. Breast Cancer Res 2009;11:R91.
56. Coughlin SS, Piper M. Genetic polymorphisms and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1999;8:1023–32.
57. Green R. Indicators for assessing folate and vitamin B-12 status and for monitoring the efficacy of intervention strategies. Am J Clin Nutr 2011;94:666S–72S.
58. EFSA Panel on Dietetic Products NaAN. Scientific opinion on dietary reference values for cobalamin (vitamin B12). EFSA J 2015;13:4150.